Loading chat...
MO HB695
Bill
Status
Introduced
2/25/2013
Primary Sponsor
Dwight Scharnhorst
Click for details
AI Summary
- Health benefit plans covering cancer chemotherapy cannot require higher copayments, deductibles, or coinsurance for orally administered anticancer medications than for intravenously administered or injected cancer medications
- Health carriers cannot achieve compliance by increasing out-of-pocket costs for intravenously administered or injected cancer chemotherapy agents
- Health carriers may still require prior authorization and impose other utilization controls for chemotherapy coverage
- Exempts supplemental insurance policies including life care contracts, accident-only policies, specified disease policies, Medicare supplements, long-term care policies, and short-term major medical policies of six months or less
- Applies definitions of "health benefit plan" and "health carrier" from section 376.1350 of Missouri law
Legislative Description
Prohibits a health benefit plan from requiring a higher out-of-pocket cost for an oral anti-cancer medication than for an intravenously administered cancer medication
Last Action
HCS Reported Do Pass (H)
4/4/2013
Committee Referrals
Rules4/4/2013
Special Standing Committee on Emerging Issues in Health Care2/28/2013
Full Bill Text
No bill text available